SLU-PP-332 and BAM-15 are studied for exercise-mimetic metabolic effects, mitochondrial biogenesis, fat oxidation, and enhanced energy expenditure. Physician-reviewed. Prescription required.
SLU-PP-332 is a research small molecule being studied primarily for its ability to activate energy metabolism pathways by targeting nuclear receptors that control mitochondrial and oxidative gene programs. It has been described as an "exercise-mimetic" compound because it pharmacologically induces cellular responses similar to endurance training in preclinical models. BAM15 is a mitochondrial uncoupler and metabolic modulator studied primarily in preclinical models, with mechanisms that center on disrupting normal oxidative phosphorylation to increase energy expenditure and improve metabolic flexibility.
Together, SLU-PP-332 and BAM15 produce complementary exercise-mimetic and metabolic effects through distinct but synergistic mechanisms. These compounds represent an emerging class of metabolic activators under active investigation. Individual outcomes may differ. This protocol is not intended to diagnose, treat, cure, or prevent any disease.
| Mechanism | Biological Effect |
|---|---|
| ERRα/β/γ agonism | Activation of energy metabolism gene programs |
| PGC1α transcriptional coactivation | Mitochondrial biogenesis |
| Upregulated oxidative/FAO genes | Increased fat oxidation |
| Enhanced ATP production | Higher energy output |
| Endurance-like genetic signature | Exercise-mimetic metabolic adaptations |
| Mechanism | Biological Effect |
|---|---|
| Mitochondrial uncoupling | Increased respiration, energy expenditure |
| AMPK activation | Enhanced fat oxidation & glucose uptake |
| Mitochondrial biogenesis (PGC1α) | Improved oxidative capacity |
| Altered substrate use | Reduced adiposity |
| Reduced ROS/inflammation | Less oxidative/inflammatory stress |
Your physician will determine eligibility based on your complete health intake. The following profiles are commonly associated with SLU-PP-332 / BAM-15 protocol candidates in clinical practice:
Exercise Mimetics
Individuals seeking physician-supervised metabolic activation with exercise-mimetic mechanisms.
Fat Oxidation
Individuals pursuing physician-reviewed fat metabolism enhancement through mitochondrial pathways.
Mitochondrial Optimization
Individuals with mitochondrial decline seeking physician-supervised biogenesis support.
Advanced Performance
High-output individuals under physician supervision pursuing cutting-edge metabolic compounds.
Determine your candidacy
A physician will review your intake and make eligibility determination within 24–48 hours.
All outcome language below reflects what has been observed in clinical and preclinical settings. Individual outcomes may differ significantly. These are not guarantees.
Dosing is determined individually by your assigned physician. The following represents typical ranges discussed in clinical literature. Do not self-administer or adjust dosing without physician guidance.
Typical Range
Physician-determined (emerging compounds)
Administration
Oral or subcutaneous (physician-determined)
Duration
Physician-determined cycles
Frequency
Physician-determined
These ranges are indicative only. Your physician will prescribe the specific dose and schedule appropriate for your clinical profile.
Physician consultation — Virtual intake review and protocol consultation with your assigned NP/MD
Valid prescription — Issued by your attending physician upon protocol approval
Pharmacy-dispensed compound — Dispensed by our licensed 503A compounding pharmacy partner
Follow-up check-in — Physician review at protocol midpoint; reorder pathway established
Your physician will review your complete health history before determining eligibility. The following are commonly reviewed clinical considerations.
Begin your SLU-PP-332 / BAM-15 protocol.
Complete your intake. Physician review within 24–48 hours.
Physician-reviewed. Pharmacy-dispensed. Prescription required before any order is fulfilled.
Prescription required. Results may vary. Individual outcomes may differ.
SLU-PP-332 is an exercise mimetic compound that activates ERR (Estrogen-Related Receptor) pathways, producing many of the metabolic benefits of aerobic exercise at the cellular level — including improved mitochondrial function and endurance.
Benefits include improved metabolic rate, increased mitochondrial biogenesis, enhanced fat oxidation, and improved cardiovascular endurance markers — without exercise. It is used as a metabolic optimizer in longevity protocols.
SLU-PP-332 is of interest for metabolic syndrome, age-related metabolic decline, patients unable to exercise, and biohackers seeking cellular fitness optimization.
Yes. SLU-PP-332 is a cutting-edge research compound. Verum Health offers it under physician supervision with appropriate informed consent and monitoring.